Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock
Clicks: 176
ID: 269340
2010
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
176 views
19 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #14 of 17 articles by views in critical care
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
It has been proposed that doses of amikacin of >15 mg/kg should be used in conditions associated with an increased volume of distribution (V[d] ), such as severe sepsis and septic shock. The primary aim of this study was to determine whether 25 ...
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (42 words).
Try re-searching for a better abstract.
| Reference Key |
jacobs2010criticalrevisiting
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Fabio Silvio Taccone, Pierre-François Laterre, Herbert Spapen, Thierry Dugernier, Isabelle Delattre, Brice Layeux, Daniel De Backer, Xavier Wittebole, Pierre Wallemacq, Jean-Louis Vincent, Frédérique Jacobs;Fabio Silvio Taccone;Pierre-François Laterre;Herbert Spapen;Thierry Dugernier;Isabelle Delattre;Brice Layeux;Daniel De Backer;Xavier Wittebole;Pierre Wallemacq;Jean-Louis Vincent;Frédérique Jacobs; |
| Journal | critical care |
| Year | 2010 |
| DOI |
10.1186/cc8945
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.